Class II Major Histocompatibility Complex Antigen Expression on Unstimulated and Gamma-Interferon Stimulated Monocytes from Patients with Multiple Sclerosis, Rheumatoid Arthritis and Normal Controls

References

• Haire M. Significance of virus antibodies in multiple sclerosis. Br Med Bull 1977; 33: 40–44
   PubMed Web of Science ®Google Scholar
• Shirodaria P V, Fraser K B, Armstrong M, Roberts S D. Measles virus-specific antibodies and immunoglobin M antiglobulin in sera from multiple sclerosis and rheumatoid arthritis patients. Infection Immunity 1979; 25: 408–416
   PubMedGoogle Scholar
• Goust J M, Hoffman P M, Pryjma J, Hogan E L, Fudenberg H H. Defective immunoregulation in multiple sclerosis. Ann Neurol 1980; 8: 526–533
   PubMedGoogle Scholar
• Craig J C, Haire M, Millar J HD, Fraser K B, Merritt J D. Immunological control of Epstein-Barr virus-transformed lymphocytes in multiple sclerosis. Clin Immunol Immunopathot 1983; 29: 86–93
   PubMedGoogle Scholar
• Armstrong M A, Haire M. Ecto-5′-nucleotidase activity in B and T lymphocytes and monocytes of patients with multiple sclerosis. Ann Neurol 1986; 19: 94–96
   PubMedGoogle Scholar
• Armstrong M A, Shah S, Hawkins S A, Bell A L, Roberts S D. Reduction of monocyte 5′-nucleotidase activity by γ-interferon in multiple sclerosis and autoimmune diseases. Ann Neurol 1988; 24: 12–16
   PubMedGoogle Scholar
• Schreiber R D, Pace J L, Russell S W, Altman A, Katz D H. Macrophage activating factor produced by a T cell hybridoma:-physiochemical and biosynthetic resemblance to γ-interferon. J Immunol 1983; 131: 826–832
   PubMed Web of Science ®Google Scholar
• Gonwa T A, Frost J P, Karr R W. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-γ. J Immunol 1986; 137: 519–524
   PubMedGoogle Scholar
• Bach F H. The HLA class II genes and products of the HLA-D region. Immunol Today 1985; 6: 89–94
   PubMedGoogle Scholar
• Unanue E R. Antigen-presenting function of the macrophage. Ann Rev Immunol 1984; 2: 395–428
   PubMed Web of Science ®Google Scholar
• Janeway C A, Bottomly K, Babich J. Quantitative variation in la antigen expression plays a central role in immunoregulation. Immunol Today 1984; 5: 99–105
   PubMedGoogle Scholar
• Armstrong M A, Crockard A D, Hawkins S A, McNeil T A. Multiple sclerosis and gamma interferon. Lancet 1987; i: 1369–1370
   Google Scholar
• McDonald W I, Halliday A M. Diagnosis and Classification of multiple sclerosis. Br Med Bull 1977; 33: 4–9
   PubMed Web of Science ®Google Scholar
• Ropes M W, Bennett G A, Cobb S, et al. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–176
   PubMedGoogle Scholar
• Boyum A. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. Scand J Clin Lab Invest 1968; 21(suppl 97)52–76
   Google Scholar
• Lanier L L, Warner N L. Paraformaldehyde fixation of haemato poietic cells for quantitative flow cytometry (FACS) analysis. J Immunol Meth 1981; 47: 25–30
   PubMed Web of Science ®Google Scholar
• Fertsch-Ruggio D, Schoenberg D R, Vogel S N. Induction of macrophage la antigen expression by rIFN-γ and down regulation by lFN-α/β and dexamethasone are regulated transcriptionally. J Immunol 1988; 141: 1582–1589
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Shimonkevitz R, Kappler J, Marrack P. Effect of prostaglandin E2 on the γ-interferon induction of antigen-presenting ability in P388D1 cells and on IL-2 production by T-Cell hybridomas. Cell Immunol 1985; 90: 154–166
   PubMedGoogle Scholar
• Dore-Duffy P, Donaldson J O, Koff T, Longo M, Perry W. Prostaglandin release in multiple sclerosis: Correlation with disease activity. Neurology 1986; 36: 1587–1590
   PubMedGoogle Scholar
• Seitz M, Hunstein W. Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. Ann Rheu Dis 1985; 44: 438–445
   PubMed Web of Science ®Google Scholar
• Koeffler H P, Ranyard J, Yelton L, Billing R, Bohman R. γ-Interferon induces expression of the HLA-D antigens on normal and leukaemic human myeloid cells. Proc Natl Acad Sci USA 1984; 81: 4080–4084
   PubMed Web of Science ®Google Scholar
• Kissonerghis A M, Maini R N, Feldman M. High rate of HLA class II mRNA synthesis in rheumatoid arthritis joints and its persistence in culture: Down regulation by recombinant Interleukin 2. Scand J Immunol 1989; 29: 73–82
   PubMedGoogle Scholar
• Bergroth V, Zvaifler N J, Firestein G S. Cytokines in inflammatory arthritis. III. Rheumatoid arthritis monocytes are not usually sensitive to γ-interferon, but have defective γ-interferon-mediated HLA-DQ and HLA-DR induction. Arthritis and Rheum 1989; 32: 1074–1079
   PubMedGoogle Scholar
• Alvaro-Garcia J M, Zvaifler N J, Firestein G S. Cytokines in Inflammatory Arthritis. IV. Granulocyte-macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: A possible role in rheumatoid arthritis. J Exp Med 1989; 170: 865–875
   PubMed Web of Science ®Google Scholar
• Philip R, Epstein L B. Tumour necrosis factor as immunomod-ulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature 1986; 323: 86–89
   PubMed Web of Science ®Google Scholar
• Dinarello C A, Cannon J G, Wolff S M, Bernheim H A, Beutler B, Cerami A, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433–1450
   PubMed Web of Science ®Google Scholar
• Gerrard T L, Siegel J P, Dyer D R, Zoon K C. Differential effects of interferon-a and interferon-γ on interleukin 1 secretion by monocytes. J Immunol 1987; 138: 2535–2540
   PubMedGoogle Scholar
• Nedwin G E, Svedersky L P, Bringman T S, Palladino M A, Goeddel D V. Effect of interleukin 2, interferon-γ and mitogens on the production of tumour necrosis factors α and β. J Immunol 1986; 13S: 2492–2497
   Google Scholar
• Swingler R, Compston D AS. The distribution of multiple sclerosis in the United Kingdom. J Neurosurg Psych 1986; 49: 1115–1124
   PubMedGoogle Scholar
• Hawkins S A, Cullen C, Middleton D, Morrow J I. HLA antigens and multiple sclerosis in N. Ireland. Irish J Med Sci 1990; 159: 68–69
   PubMedGoogle Scholar
• Gonwa T A, Picker L J, Raff H V, Goyert S M, Silver J, Stobo J. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an la determinant distinct from HLA-DR. J Immunol 1983; 130: 706–711
   PubMed Web of Science ®Google Scholar
• Suitters A, Rose M, Higgins A, Yacoub M H. MHC antigen expression in sequential biopsies from cardiac transplant patients: correlation with rejection. Clin Exp Immunol 1987; 69: 575–583
   PubMedGoogle Scholar
• van Furth R, Sluiter W. Current views on the ontogeny of macrophages and the humoral regulation of monocytopoiesis. Trans Royal Soc Trop MedHyg 1983; 77: 614–619
   PubMedGoogle Scholar